249 related articles for article (PubMed ID: 2211593)
1. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa.
Callander NS; Rao LV; Nordfang O; Sandset PM; Warn-Cramer B; Rapaport SI
J Biol Chem; 1992 Jan; 267(2):876-82. PubMed ID: 1730676
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa.
Wesselschmidt R; Likert K; Girard T; Wun TC; Broze GJ
Blood; 1992 Apr; 79(8):2004-10. PubMed ID: 1562726
[TBL] [Abstract][Full Text] [Related]
4. Evidence that plasma lipoproteins inhibit the factor VIIa-tissue factor complex by a different mechanism that extrinsic pathway inhibitor.
Kondo S; Kisiel W
Blood; 1987 Dec; 70(6):1947-54. PubMed ID: 3315045
[TBL] [Abstract][Full Text] [Related]
5. Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII.
Nakagaki T; Foster DC; Berkner KL; Kisiel W
Biochemistry; 1991 Nov; 30(45):10819-24. PubMed ID: 1932002
[TBL] [Abstract][Full Text] [Related]
6. The lipoprotein-associated coagulation inhibitor.
Broze GJ; Girard TJ; Novotny WF
Prog Hemost Thromb; 1991; 10():243-68. PubMed ID: 2008533
[TBL] [Abstract][Full Text] [Related]
7. Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation.
Rao LV; Rapaport SI
Blood; 1987 Feb; 69(2):645-51. PubMed ID: 3492226
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of proteolytic fragments of human factor VIIa which inhibit the tissue factor-enhanced amidolytic activity of factor VIIa.
Kazama Y; Pastuszyn A; Wildgoose P; Hamamoto T; Kisiel W
J Biol Chem; 1993 Aug; 268(22):16231-40. PubMed ID: 8344908
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor-dependent autoactivation of human blood coagulation factor VII.
Yamamoto M; Nakagaki T; Kisiel W
J Biol Chem; 1992 Sep; 267(27):19089-94. PubMed ID: 1527033
[TBL] [Abstract][Full Text] [Related]
11. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.
Broze GJ; Warren LA; Novotny WF; Higuchi DA; Girard JJ; Miletich JP
Blood; 1988 Feb; 71(2):335-43. PubMed ID: 3422166
[TBL] [Abstract][Full Text] [Related]
12. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.
Welsch DJ; Novotny WF; Wun TC
Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340
[TBL] [Abstract][Full Text] [Related]
13. Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI.
Lindahl AK; Abildgaard U; Larsen ML; Staalesen R; Hammer AK; Sandset PM; Nordfang O; Beck TC
Thromb Res; 1991 Jun; 62(6):607-14. PubMed ID: 1926055
[TBL] [Abstract][Full Text] [Related]
14. Immunoaffinity purification and characterization of lipoprotein-associated coagulation inhibitors from Hep G2 hepatoma, Chang liver, and SK hepatoma cells. A comparative study.
Wun TC; Huang MD; Kretzmer KK; Palmier MO; Day KC; Bulock JW; Fok KF; Broze GJ
J Biol Chem; 1990 Sep; 265(27):16096-101. PubMed ID: 2168880
[TBL] [Abstract][Full Text] [Related]
15. Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin.
Sandset PM; Abildgaard U
Haemostasis; 1991; 21(4):219-39. PubMed ID: 1794748
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma.
Novotny WF; Girard TJ; Miletich JP; Broze GJ
J Biol Chem; 1989 Nov; 264(31):18832-7. PubMed ID: 2553722
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation. Synergistic effect in combination with tissue factor pathway inhibitor.
van 't Veer C; Golden NJ; Kalafatis M; Mann KG
J Biol Chem; 1997 Mar; 272(12):7983-94. PubMed ID: 9065469
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
Rao LV; Ruf W
Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
[TBL] [Abstract][Full Text] [Related]
19. Human plasma and recombinant factor VII. Characterization of O-glycosylations at serine residues 52 and 60 and effects of site-directed mutagenesis of serine 52 to alanine.
Bjoern S; Foster DC; Thim L; Wiberg FC; Christensen M; Komiyama Y; Pedersen AH; Kisiel W
J Biol Chem; 1991 Jun; 266(17):11051-7. PubMed ID: 1904059
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces.
Hamamoto T; Yamamoto M; Nordfang O; Petersen JG; Foster DC; Kisiel W
J Biol Chem; 1993 Apr; 268(12):8704-10. PubMed ID: 8473315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]